Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.57 |
| ▸ | PLAU | P00749 | 7/20 | 0.52 |
| ▸ | HPN | P05981 | 7/20 | 0.52 |
| ▸ | BMP1 | P13497 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.43 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
| ▸ | MMP14 | P50281 | 1/20 | 0.43 |
| ▸ | ADAM8 | P78325 | 1/20 | 0.43 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALB | P02768 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl P-Toluenesulfonyl-L-Argininate SCHEMBL2853451 | 1.00 | ITGB3 (0.57) | ITGB3ITGA2BPLAUHPNBMP1 | |
| Methyl P-Toluenesulfonyl-L-Argininate SCHEMBL1034821 | 0.99 | ITGB3 (0.56) | ITGB3ITGA2BPLAUHPNBMP1 | |
| Methyl P-Toluenesulfonyl-L-Argininate SCHEMBL11880215 | 0.99 | ITGB3 (0.56) | ITGB3ITGA2BPLAUHPNBMP1 | |
| SCHEMBL1839480 | 0.92 | ITGB3 (0.56) | ITGB3ITGA2BPLAUHPNALDH1A1 | |
| SCHEMBL1839478 | 0.92 | ITGB3 (0.56) | ITGB3ITGA2BPLAUHPNALDH1A1 | |
| Methoxymethane SCHEMBL8925022 | 0.90 | ITGB3 (0.67) | ITGB3ITGA2BPLAUHPNMMP2 | |
| SCHEMBL27734963 | 0.90 | BMP1 (0.52) | ITGB3ITGA2BBMP1MMP2MMP9 | |
| SCHEMBL1244355 | 0.90 | ITGB3 (0.60) | ITGB3ITGA2BPLAUHPNALDH1A1 | |
| SCHEMBL17318886 | 0.89 | ITGB3 (0.54) | ITGB3ITGA2BPLAUHPNALDH1A1 | |
| Hydrochloric Acid SCHEMBL7319933 | 0.88 | ITGB3 (0.59) | ITGB3ITGA2BPLAUHPNALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720329-A1 | REFERENCE MATERIAL COMPRISING NUCLEIC ACIDS HAVING A FRAGMENTATION AND NUCLEOSOME PROFILE AND DIAGNOSTIC METHOD | SensID GmbH (DE) | 2026-04-08 | — | — | EP | claimed |
| WO-2024246014-A1 | REFERENCE MATERIAL COMPRISING NUCLEIC ACIDS HAVING A FRAGMENTATION AND NUCLEOSOME PROFILE AND DIAGNOSTIC METHOD | SENSID GMBH (DE) | 2024-12-05 | — | — | WO | claimed |
| EP-4467659-A1 | REFERENCE MATERIAL COMPRISING NUCLEIC ACIDS WITH A FRAGMENTATION AND NUCLEOSOME PROFILE AND DIAGNOSIS | SensID GmbH (DE) | 2024-11-27 | — | — | EP | claimed |
| US-20020187520-A1 | ALLERGEN/ INFLAMMATORY TESTING AND DIAGNOSIS | HELM BIRGIT ANNA (GB) | 2002-12-12 | — | — | US | claimed |
| US-6177268-B1 | DISSOLVING TRYPSIN IN BUFFER SOLUTION HAVING PH AT WHICH TRYPSIN IS ACTIVE, PKA IS HIGHER THAN PH OF BUFFER, AND SOLUTION HAS CALCIUM AND MANGANESE IONS; STORAGE STABILITY | ARKRAY, INC. (JP) | 2001-01-23 | — | — | US | claimed |
| EP-0671004-A1 | ALLERGEN/INFLAMMATORY TESTING AND DIAGNOSIS | EURO/DPC LIMITED (GB) | 1995-09-13 | — | — | EP | claimed |
| WO-1994012876-A1 | ALLERGEN/INFLAMMATORY TESTING AND DIAGNOSIS | EURO/DPC LIMITED (GB) | 1994-06-09 | — | — | WO | claimed |
| JP-57016698-A | — | — | None | — | — | JP | disclosed |
| JP-3004790-A | — | — | None | — | — | JP | disclosed |
| EP-4720329-A1 | REFERENCE MATERIAL COMPRISING NUCLEIC ACIDS HAVING A FRAGMENTATION AND NUCLEOSOME PROFILE AND DIAGNOSTIC METHOD | SensID GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| US-12559544-B2 | Antibodies that bind human metapneumovirus fusion protein and their use | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4686765-A1 | METHOD FOR PROGNOSIS OF BLADDER CANCER | Istituto Europeo di Oncologia S.r.l. (IT) | 2026-02-04 | — | — | EP | disclosed |
| US-20260007705-A1 | PROBIOTIC COMPOSITIONS FOR PRODUCTION OF DOPAMINE | UNIV IOWA STATE RES FOUND INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-4224342-A | ANTI-PLASMIN AND ANTI-TRYPSIN ACTIVITY | ONO PHARMACEUTICAL CO., LTD. (JP) | 1980-09-23 | — | — | US | disclosed |
| US-4214093-A | PROTEOLYTIC ENZYME INHIBITORS | TORII & CO., LTD. (JP) | 1980-07-22 | — | — | US | disclosed |
| EP-0008746-A1 | Alpha-(N-arylsulfonyl-L-argininamides, processes for their preparation and pharmaceutical compositions containing these substances | MITSUBISHI KASEI CORPORATION (JP) | 1980-03-19 | — | — | EP | disclosed |
| US-4182897-A | ENZYME INHIBITORS FOR PROTEOLYTIC ENZYMES | TORII & CO., LTD. (JP) | 1980-01-08 | — | — | US | disclosed |
| US-4118575-A | Derivatives of para-guanidino-L-phenylalanine and methods of preparing them | CHOAY S.A. (FR) | 1978-10-03 | — | — | US | disclosed |
| US-4075405-A | CYANOGEN HALIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1978-02-21 | — | — | US | disclosed |
| US-3954678-A | Semipermeable microcapsules containing a silica gel | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559544-B2 | Antibodies that bind human metapneumovirus fusion protein and their use | FCGR3B, FCGR2A, FCGR1A | ITGB3 2695/4885ITGA2B 3033/4885PLAU 3428/4885 |
| US-20260007705-A1 | PROBIOTIC COMPOSITIONS FOR PRODUCTION OF DOPAMINE | PRLHR, SLC6A2, TPH2 | ITGB3 4243/4885ITGA2B 4097/4885PLAU 2655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.